CAIV-T or TIV

BIOLOGICAL2 trials

Sponsors

MedImmune LLC

Conditions

InfluenzaRespiratory Tract Infections

Phase 2

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older

CompletedNCT00192153

MedImmune LLCInfluenza

Start: 2001-07-31End: 2001-10-31Target: 240Updated: 2021-09-13

Phase 3

Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children

CompletedNCT00192205

MedImmune LLCRespiratory Tract Infections

Start: 2002-10-31End: 2003-06-30Target: 2200Updated: 2006-10-03